Request Appointment
710 W 168th StNew York, NY 10032
Fax+1 212-305-1145
Overview of Dr. Marder
Dr. Karen Marder is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Weill Cornell Medicine and has been in practice 34 years. She is one of 475 doctors at New York-Presbyterian Hospital and one of 216 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Neurology. She has more than 100 publications and over 500 citings.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1984 - 1987
Weill Cornell MedicineClass of 1983
Certifications & Licensure
FL State Medical License 2023 - Present
NY State Medical License 1984 - 2027
NJ State Medical License 2022 - 2025
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2013-2014
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- New York Magazine: Top Doctors Castle Connolly, 2012-2013
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- Spiritual Well-Being and Phenoconversion in Huntington's Disease: Analysis from the Prospective Huntington at Risk Observational Study.Leonard L Sokol, Marissa C Ashner, Danny Bega, Benzi M Kluger, Alexander K Smith
Journal of Palliative Medicine. 2025-03-05 - Mini-mental status examination phenotyping for Alzheimer's disease patients using both structured and narrative electronic health record features.Betina Idnay, Gongbo Zhang, Fangyi Chen, Casey N Ta, Matthew W Schelke
Journal of the American Medical Informatics Association. 2025-01-01 - 1 citationsWhat research participants say about their research experiences in Empowering the Participant Voice: Outcomes and actionable data.Rhonda G Kost, Joseph Andrews, Ranee Chatterjee, Alex C Cheng, Lisa Connally
Journal of Clinical and Translational Science. 2025-01-01
Press Mentions
Parkinson's Disease Foundation Announces $4 Million in Research Investments to Solve, Treat and End Parkinson's DiseaseJune 9th, 2016
Diagnosing and Treating Early,Stage Alzheimer'sFebruary 14th, 2007
Following a Mediterranean Diet Not Associated with Delay to Clinical Onset of Huntington's DiseaseFebruary 10th, 2016
Grant Support
- Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24 Clinical Trial Not Allowed)COLUMBIA UNIVERSITY HEALTH SCIENCES2018–2028
- Columbia University Medical Center - Weill Cornell Medical Center Next SiteNational Institute Of Neurological Disorders And Stroke2011
- Genetic Epidemiology Of Parkinson'S DiseaseNational Institute Of Neurological Disorders And Stroke2010
- Genetic Epidemiology Of Parkinson'S DiseaseNational Institute Of Neurological Disorders And Stroke2004–2008
- Selegiline Transdermal SystemNational Center For Research Resources2004–2005
- PREDICT-HDNational Center For Research Resources2004–2005
- Pilot Huntington'S At Risk Observational Study (PHAROS)National Center For Research Resources2004–2005
- Neurocognitive Function, HIV Load And Surrogate MarkersNational Center For Research Resources2004
- Genetic Epidemiology Of Parkinson'S DiseaseNational Center For Research Resources2004
- CrestNational Center For Research Resources2004
- Genetic Epidemiology Of Parkinsons DiseaseNational Institute Of Neurological Disorders And Stroke1998–2003
- Pilot Huntington'S At Risk Observational Study (PHAROS)National Center For Research Resources2000–2002
- Plasma Viral Load And Cognitive Decline In Advanced HIV InfectionNational Institute Of Neurological Disorders And Stroke1999–2002
- Pilot Efficacy Study Of CPI 1189 In HIV Infect Indiv W/ Cognit &MotoNational Center For Research Resources1999–2002
- Neurocognitive Function, HIV Load &Surrogate MarkersNational Center For Research Resources1999–2002
- Genetic Epidemiology Of Parkinsons DiseaseNational Center For Research Resources1999–2002
- Phase III Trial Of 1592U89 In HIV-1 Patients With AIDS DementiaNational Center For Research Resources1998–2002
- Co-Enzyme Q10 And Remacemide--Evaluation In Huntington'S DiseaseNational Center For Research Resources1998–2002
- Selegiline Transdermal System Treatment Of HIV Associated Cognitive ImpairmentNational Center For Research Resources1998–2000
- Lexipafant In HIV DementiaNational Center For Research Resources1998–1999
- Plasma Viral Load And Cognitive Decline In Advanced HIV InfectionNational Institute Of Neurological Disorders And Stroke1998
- Genetic / Environmental Influences--Dementia In Parkinson'S DiseaseNational Institute On Aging1996–1998
- Randomized Trial Of OPG 14117 In Huntingtons DiseaseNational Center For Research Resources1996
- ACTG 243--Pml StudyNational Center For Research Resources1996
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
